# myADA

> myADA is myNEO Therapeutics’ in-silico Anti-Drug Antibody (ADA) risk prediction platform for biologics. It centers on advanced MHC class II epitope immunogenicity modeling to flag high-risk candidates, identify immunogenicity hotspots, and support design-stage control of biologic immunogenicity. myADA is a standalone myX platform — not part of the ImmunoEngine neoantigen pipeline.

## Public pages

- [Home](https://myada.myneotx.com/): Product overview and capabilities
- [Contact](https://myada.myneotx.com/contact): Get in touch / request a demo
- [Documentation](https://myada.myneotx.com/documentation): Docs hub
- [Manual](https://myada.myneotx.com/documentation/manual): User guide
- [Technical](https://myada.myneotx.com/documentation/technical): Release notes

## Related

- [myADA on myNEO Solutions](https://www.myneotx.com/solutions#myada)
- [myNEO Therapeutics](https://www.myneotx.com/)
- Contact: info@myneotx.com